Regulatory policy, value of knowledge assets and innovation strategy: The case of the Orphan Drug Act

Zaur Rzakhanov

首页> 外文期刊>Research policy >Regulatory policy, value of knowledge assets and innovation strategy: The case of the Orphan Drug Act

【24h】

Regulatory policy, value of knowledge assets and innovation strategy: The case of the Orphan Drug Act

机译：监管政策，知识资产的价值和创新战略：《孤儿药法案》的案例

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The U.S. Orphan Drug Act provides R&D incentives to drug-makers that go beyond statutory patent protection. The study explores the act's effect on financial returns to innovation and on the strategy of orphan drug development. Results indicate that the fi

机译：《美国孤儿药法案》为药品生产商提供了超出法定专利保护范围的研发激励措施。该研究探讨了该法案对创新的财务回报和孤儿药物开发战略的影响。结果表明

著录项

来源
《Research policy》 |2008年第4期|673-689|共17页
作者
Zaur Rzakhanov;
展开▼
作者单位

展开▼
收录信息美国《科学引文索引》(SCI);美国《工程索引》(EI);
原文格式 PDF
正文语种 eng
中图分类
关键词
innovation; RD policy; RD strategy; orphan drug act;

机译：革新;研发政策;研发策略;孤儿药法案;

相似文献

外文文献
中文文献
专利

1. Challenges in orphan drug development and regulatory policy in China [J] . Alice Cheng, Zhi Xie Orphanet journal of rare diseases . 2017,第1期

机译：中国孤儿药物开发和监管政策面临的挑战
2. Knowledge Creation, Use and Innovation: The Role of Urban and Regional Innovation Strategies and Policies [J] . MICHAEL A. GOLDBERG European Planning Studies . 2006,第5期

机译：知识创造，利用和创新：城市和区域创新战略与政策的作用
3. Public opinion of drug treatment policy: Exploring the public's attitudes, knowledge, experience and willingness to pay for drug treatment strategies [J] . MathesonC., JaffrayM., RyanM., The International journal of drug policy . 2014,第3期

机译：药物治疗政策的公众舆论：探索公众的态度，知识，经验和支付药物治疗策略的意愿
4. Policy and Divergent Strategies of Knowledge Management: European Lessons Useful for Chinese Innovation Policy? [C] . Hans VAN DEN BROEK 第五届技术与创新管理国际研讨会 . 2007

机译：知识管理的政策和不同策略：对中国创新政策有用的欧洲经验教训？
5. Meta-Analysis to Identify and Evaluate Factors Associated with Regulatory Approval of Orphan Drugs (OD) to Develop an Algorithm for Predicting Regulatory Approval (Success) and to Develop a Standardized Tool to Improve Orphan Drug Portfolio Decision-Making [D] . Florent, Milky C. 2019

机译：荟萃分析，以识别和评估与孤儿药物监管批准（OD）相关的因素，以开发预测监管批准（成功）的算法，并开发标准化工具以改善孤儿药物投资组合决策
6. Challenges in orphan drug development and regulatory policy in China [O] . Alice Cheng, Zhi Xie 2017

机译：中国孤儿药物开发和监管政策面临的挑战
7. Challenges in orphan drug development and regulatory policy in China [O] . Alice Cheng, Zhi Xie 2017

机译：中国孤儿药物开发和监管政策面临的挑战

Regulatory policy, value of knowledge assets and innovation strategy: The case of the Orphan Drug Act

摘要

著录项

相似文献

相关主题

期刊订阅